AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Ruhoglim M 1mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Euphony Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Ruhoglim M 1mg/500mg Tablet SR

Diabetol Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetol Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is vital, even with controlled glucose levels; abrupt cessation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive approach including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications are crucial for diabetes control. The primary side effect is hypoglycemia (low blood sugar). Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with readily available glucose sources (e.g., sugary foods, juice). Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Inform your doctor of any history of heart conditions before starting treatment, as it may be unsuitable. Pregnant or breastfeeding individuals should seek medical advice prior to use. Regular blood glucose monitoring, along with potential blood tests for cell counts and liver function, will be necessary as directed by your healthcare provider.

Primary Ingredients of Ruhoglim M 1mg/500mg Tablet SR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Ruhoglim M 1mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Ruhoglim M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. Ruhoglim M 1mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Ruhoglim M 1mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Ruhoglim M 1mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Ruhoglim M 1mg/500mg Extended-Release Tablets should be administered with a meal.

How Ruhoglim M 1mg/500mg Tablet SR works:

Ruhoglim M, a sustained-release tablet containing 1mg glimepiride and 500mg metformin, combines two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Ruhoglim M 1mg/500mg SR tablets with alcohol is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Ruhoglim M 1mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers before prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Prolonged-release Ruhoglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates a potential for infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Ruhoglim M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. Ruhoglim M 1mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Ruhoglim M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. A reduced initial dose is typically advised for those with mild to moderate hepatic dysfunction; the medication is unsuitable for individuals with severe liver disease.

What if you forget to take Ruhoglim M 1mg/500mg Tablet SR :

Should you forget a Ruhoglim M 1mg/500mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Ruhoglim M 1mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Ruhoglim M 1mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Ruhoglim M 1mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these symptoms, discontinue Ruhoglim M 1mg/500mg Tablet SR and seek immediate medical attention.
Ruhoglim M 1mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Ruhoglim M 1mg/500mg Tablet SR may cause common side effects such as low blood sugar, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Ruhoglim M 1mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Ruhoglim M 1mg/500mg SR Tablets can induce hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Ruhoglim M 1mg/500mg SR tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Ruhoglim M 1mg/500mg Tabl...
45
MRP 55
18% off